Cancer News

eCancer News
Adding radiation to chemotherapy may improve some lung cancer outcomes

According to a small study, for patients with limited metastatic non-small cell lung cancer (NSCLC), adding radiation therapy to chemotherapy with may curb disease progression dramatically.

Read full article
eCancer News
Seeking clarity on CT scans after lung cancer surgery

A trial did not show a difference in overall survival between patients with non-small cell lung cancer who received CT scans as part of their follow-up, and those who did not.

Read full article
eCancer News
Pembrolizumab: A new treatment option for metastatic lung cancer

Pembrolizumab has been approved by the FDA, for the first-line treatment of patients with metastatic non-small cell lung cancer. 

Read full article
eCancer News
Short-term training improves aerobic performance in lung cancer

High-intensity exercise training before surgery appears to improve aerobic performance in non-small cell lung cancer patients but it does not reduce the complications after tumor resection.

Read full article
eCancer News
Atezolizumab got approved for non-small cell lung cancer

Atezolizumab treatment got approved by FDA (Food and Drug Administration) for patients with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following platinum-containing chemotherapy.

Read full article
eCancer News
New treatment option for patients with advanced lung cancer

Pembrolizumab is considered to be the new option for first line treatment of patients with advanced lung cancer. These clinical results were presented at the ESMO 2016 Congress.

Read full article
eCancer News
Checkpoint inhibitors benefit survival in non-small-cell lung cancer

The first phase 3 study of PD-L1 inhibitor atezolizumab, revealed that survival rate can be significantly increased compared to standard chemotherapy, in previously-treated non-small-cell lung cancer patients. 

Read full article
MedPage Today
Stereotactic body radiotherapy prolongs survival in lung cancer patients

Stereotactic body radiotherapy (SBRT) can improve outcomes in patients with non-small cell lung cancer (NSCLC). According to research, lung-cancer specific survival can be prolonged significantly. 

Read full article
eCancer News
Intense radiation scheme can help non-small cell lung cancer patients

Some non-small cell lung cancer patients (stage 2 & 3) cannot receive surgery or chemoradiation. For them, hypo-fractionated radiation therapy results in similar outcomes, fewer side effects and shorter treatment time compared to conventional therapy.

Read full article
Science Daily
Brain metastasis in lung cancer: is brain radiotherapy beneficial?

Similar quality of life for lung cancer patients with brain metastasis treated with whole brain radiotherapy compared to those who didn’t, an analysis shows. Whole brain radiotherapy induced no positive results on length or quality of survival over treatment with steroids and other supportive care.

Read full article
MedPage Today
Olanzapine prevented chemotherapy-induced nausea

Patients undergoing chemotherapy experienced no nausea or vomiting after including olanzapine (Zyprexa) to their prophylactic drug combination, a phase 3 study reveals.  In addition, no serious adverse events and no discontinuations due to toxic effects were observed.

Read full article
eCancer News
A diagnosis of high cholesterol led to increased cancer survival

A diagnosis of high cholesterol led to reduced mortality and improved survival in in patients with lung, breast, prostate and bowel cancer, the four most common cancers in the UK. According to scientists, medications used for high cholesterol such as statins may be producing this effect.

Read full article
Reuters
Immunotherapy Keytruda prolonged survival in lung-cancer patients

Merck’s Keytruda immunotherapy prolonged survival without disease progression in advanced lung cancer patients, the results of a large trial show.  The trial was stopped earlier as these favorable results allowed patients to switch their treatment over to Keytruda.  

Read full article
Science Daily
Is chemotherapy beneficial for non-small cell lung cancer patients?

A new large analysis showed that patients with stage IB non-small cell lung cancer lived longer with adjuvant chemotherapy treatment. Chemotherapy improved median overall survival and 5-year overall survival regardless of tumor size.

Read full article
Science Daily
Better quality of life after surgery for mesothelioma patients

Patients with an aggressive type of cancer called malignant pleural mesothelioma improved their quality of life after surgery, a survey reveals. The operation, called pleurectomy and decortication, is generally avoided by the patients fearing a degradation of their quality of life. 

Read full article
Science Daily
Surgery improved survival in lung cancer patients

Patients with late-stage, non-small cell lung cancer who had surgery lived longer than those who didn’t, a new data analysis reveals. However, few patients undergo surgery possible due to racial and socioeconomic biases and distance from major cancer centers. 

Read full article
Reuters
Skin cancer combo shows evidence against lung cancer

Novartis's drug combination of Tafinlar and Mekinist increased progression-free survival in lung cancer patients almost up to 10 months, said the company. BRAF V600E-mutation positive lung cancer is aggressive cancer, whose patients have a poor prognosis.

Read full article
eCancer News
Early screening can save lives in lung cancer

Screening patients with a high risk of developing lung cancer can identify early stage disease, improving greatly their survival rates. These are the results of the first and only lung cancer screening trial in the UK, supporting further the implementation of a national screening programme.

Read full article
MedPage Today
Palliative care helps families facing cancer

Palliative care showed to improve caregivers’ quality of life and mood creating a powerful positive feedback loop in families facing cancer, a randomized trial showed. Family caregivers have a key role in the care of cancer patients, but the burden of the disease-associated responsibilities can negatively affect their quality of life.

Read full article
Science Daily
Older lung cancer patients live longer after surgery

Older lung cancer patients live longer after cancer surgery, almost 2 years longer than the benchmark 5-year survival rate, a new analysis shows. The researchers combined data from more than 37,000 patients.

Read full article